AQR Capital Management’s 2seventy bio TSVT Stock Holding History

AQR Capital Management’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-21,417	Closed	-$106K	–	3395
2025 Q1	$106K	Buy	+21,417	New	+$68K	﹤0.01%	3005
2024 Q4	–	Sell	-57,680	Closed	-$272K	–	2958
2024 Q3	$272K	Sell	57,680 -104,502	-64%	-$471K	﹤0.01%	2436
2024 Q2	$611K	Sell	162,182 -7,725	-5%	-$34.8K	﹤0.01%	1964
2024 Q1	$909K	Sell	169,907 -153,909	-48%	-$724K	﹤0.01%	1737
2023 Q4	$1.38M	Buy	323,816 +24,981	+8%	+$76.8K	﹤0.01%	1488
2023 Q3	$1.13M	Buy	298,835 +284,124	+1,931%	+$1.86M	﹤0.01%	1560
2023 Q2	$149K	Buy	14,711 +896	+6%	+$9.49K	﹤0.01%	2112
2023 Q1	$139K	Buy	13,815 +3,004	+28%	+$34.3K	﹤0.01%	2096
2022 Q4	$95.4K	Buy	+10,811	New	+$152K	﹤0.01%	2145

Other funds holding TSVT

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AQR Capital Management's TSVT Position: Q2 2025 in Review

AQR Capital Management sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 21,417 shares — an estimated $106K sold.

AQR Capital Management first reported a position in TSVT in Q4 2022 and held it in 9 quarters. The position peaked at $1.38M in Q4 2023. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

AQR Capital Management reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
AQR Capital Management sold 21,417 2seventy bio shares in Q2 2025, an estimated $106K.
AQR Capital Management first reported a position in 2seventy bio in Q4 2022 and held it in 9 quarters.
AQR Capital Management's 2seventy bio position peaked at $1.38M in Q4 2023.
2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on AQR Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.